A Cervical Abnormality Risk Prediction Model
- 1 July 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 17 (3) , 242-247
Abstract
Objective Human papillomavirus (HPV) infections and abnormal Pap test results are common, and most do not progress to cervical cancer. Because it is difficult to predict which mild Pap abnormalities will develop into precancerous lesions, many women undergo painful and costly evaluations and even unnecessary treatment. The objective of this study was to develop a risk prediction model based on clinical and demographic information to identify women most likely to develop significant precancerous lesions (cervical intraepithelial neoplasia grades 2/3 [CIN 2/3] or adenocarcinoma in situ [AIS]) among women with mild Pap abnormalities (atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion). Materials and Methods The Abnormal Pap Smear Registry includes women who received treatment at the Brigham and Women’s Hospital/Dana Farber Cancer Institute Pap Smear Evaluation Center beginning in 2006. It includes 1,072 women with mild cervical dysplasia (atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion) on their referral Pap test. We derived a clinical prediction model to predict the probability of developing CIN 2/3 or AIS using multivariate logistic regression with a split-sample approach. Results By the end of the follow-up, 93 of the 1,072 women developed CIN 2/3 or AIS (8.7%). There were several differences between women who developed CIN 2/3 or AIS and women who did not. However, once we put these into the regression model, the only variable that was significantly associated with CIN 2/3 or AIS was having a history of an abnormal Pap or biopsy result (odds ratio = 2.44; 95% CI =1.03–5.76). The resulting prediction model had poor discriminative ability and was poorly calibrated. Conclusions Despite accounting for known risk factors, we were unable to predict individual patients’ probability for progression on the basis of available data.Keywords
This publication has 21 references indexed in Scilit:
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical CancerJournal of Lower Genital Tract Disease, 2012
- Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission modelBMC Infectious Diseases, 2009
- Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and DeterminantsCancer Epidemiology, Biomarkers & Prevention, 2009
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markersGynecologic Oncology, 2007
- Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical CancerNew England Journal of Medicine, 2007
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Goodness‐of‐fit processes for logistic regression: simulation resultsStatistics in Medicine, 2002
- Natural history of cervical squamous intraepithelial lesions: a meta-analysis*1Obstetrics & Gynecology, 1998
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993